BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 15144397)

  • 1. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa.
    Mizoshita T; Tsukamoto T; Inada K; Ogasawara N; Hirata A; Kato S; Joh T; Itoh M; Yamamura Y; Tatematsu M
    Pathol Int; 2004 Jun; 54(6):392-400. PubMed ID: 15144397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down regulation of gastric and intestinal phenotypic expression in Epstein-Barr virus-associated stomach cancers.
    Hirano N; Tsukamoto T; Mizoshita T; Koriyama C; Akiba S; Campos F; Carrasquilla G; Carrascal E; Cao X; Toyoda T; Ban H; Miki K; Tatematsu M
    Histol Histopathol; 2007 Jun; 22(6):641-9. PubMed ID: 17357094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cdx2 transcription factor regulates claudin-3 and claudin-4 expression during intestinal differentiation of gastric carcinoma.
    Satake S; Semba S; Matsuda Y; Usami Y; Chiba H; Sawada N; Kasuga M; Yokozaki H
    Pathol Int; 2008 Mar; 58(3):156-63. PubMed ID: 18251778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis.
    Mizoshita T; Tsukamoto T; Nakanishi H; Inada K; Ogasawara N; Joh T; Itoh M; Yamamura Y; Tatematsu M
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):727-34. PubMed ID: 14557879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2.
    Ikarashi S; Nishikura K; Ajioka Y; Aoyagi Y
    Gastric Cancer; 2013 Apr; 16(2):208-19. PubMed ID: 22829163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDX2 expression is increased in gastric cancers with less invasiveness and intestinal mucin phenotype.
    Ha Kim G; Am Song G; Youn Park D; Han Lee S; Hyun Lee D; Oh Kim T; Jae Jo H; Heo J; Hwan Kang D; Cho M
    Scand J Gastroenterol; 2006 Aug; 41(8):880-6. PubMed ID: 16803685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite instability is linked to loss of hMLH1 expression in advanced gastric cancers: lack of a relationship with the histological type and phenotype.
    Mizoshita T; Tsukamoto T; Cao X; Otsuka T; Ito S; Takahashi E; Nakamura S; Nakamura T; Yamamura Y; Tatematsu M
    Gastric Cancer; 2005; 8(3):164-72. PubMed ID: 16086119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colonic and small-intestinal phenotypes in gastric cancers: relationships with clinicopathological findings.
    Mizoshita T; Tsukamoto T; Tanaka H; Takenaka Y; Kato S; Cao X; Joh T; Tatematsu M
    Pathol Int; 2005 Oct; 55(10):611-8. PubMed ID: 16185290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-evaluation of Phenotypic Expression in Differentiated-type Early Adenocarcinoma of the Stomach.
    Hayakawa M; Nishikura K; Ajioka Y; Aoyagi Y; Terai S
    Pathol Int; 2017 Mar; 67(3):131-140. PubMed ID: 28088838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis.
    Fan Z; Li J; Dong B; Huang X
    Clin Cancer Res; 2005 Sep; 11(17):6162-70. PubMed ID: 16144916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric and intestinal phenotypic correlation between exocrine and endocrine components in human stomach tumors.
    Takenaka Y; Tsukamoto T; Mizoshita T; Ogasawara N; Hirano N; Otsuka T; Ban H; Nakamura T; Yamamura Y; Kaminishi M; Tatematsu M
    Histol Histopathol; 2007 Mar; 22(3):273-84. PubMed ID: 17163401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia.
    Tsukamoto T; Inada K; Tanaka H; Mizoshita T; Mihara M; Ushijima T; Yamamura Y; Nakamura S; Tatematsu M
    J Cancer Res Clin Oncol; 2004 Mar; 130(3):135-45. PubMed ID: 14655050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas.
    Almeida R; Silva E; Santos-Silva F; Silberg DG; Wang J; De Bolós C; David L
    J Pathol; 2003 Jan; 199(1):36-40. PubMed ID: 12474224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions.
    Kim HS; Lee JS; Freund JN; Min KW; Lee JS; Kim W; Juhng SW; Park CS
    J Gastroenterol Hepatol; 2006 Feb; 21(2):438-42. PubMed ID: 16509871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cdx2 expression in pancreatic tumors: Relationship with prognosis of invasive ductal carcinomas.
    Matsumoto K; Mizoshita T; Tsukamoto T; Ogasawara N; Hirata A; Shimizu Y; Haneda M; Yamao K; Tatematsu M
    Oncol Rep; 2004 Dec; 12(6):1239-43. PubMed ID: 15547744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis.
    Roessler K; Mönig SP; Schneider PM; Hanisch FG; Landsberg S; Thiele J; Hölscher AH; Dienes HP; Baldus SE
    World J Gastroenterol; 2005 Jun; 11(21):3182-8. PubMed ID: 15929165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes.
    Tsukamoto T; Mizoshita T; Mihara M; Tanaka H; Takenaka Y; Yamamura Y; Nakamura S; Ushijima T; Tatematsu M
    Histopathology; 2005 Jun; 46(6):649-58. PubMed ID: 15910596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the intestine-specific transcription factors, Cdx1 and Cdx2, correlates shift to an intestinal phenotype in gastric cancer cells.
    Mizoshita T; Inada K; Tsukamoto T; Nozaki K; Joh T; Itoh M; Yamamura Y; Ushijima T; Nakamura S; Tatematsu M
    J Cancer Res Clin Oncol; 2004 Jan; 130(1):29-36. PubMed ID: 14615935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of mucins, SIMA, villin, and CDX2 in small-intestinal adenocarcinoma.
    Zhang MQ; Lin F; Hui P; Chen ZM; Ritter JH; Wang HL
    Am J Clin Pathol; 2007 Nov; 128(5):808-16. PubMed ID: 17951204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of osteopontin and CDX2: indications of phenotypes and prognosis in advanced gastric cancer.
    Zhang X; Tsukamoto T; Mizoshita T; Ban H; Suzuki H; Toyoda T; Tatematsu M
    Oncol Rep; 2009 Mar; 21(3):609-13. PubMed ID: 19212618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.